Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000900537 | SCV001044861 | likely benign | not provided | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000900537 | SCV005226608 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000900537 | SCV005411921 | uncertain significance | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | BS1 |
Prevention |
RCV003950557 | SCV004759297 | likely benign | SPARC-related disorder | 2023-04-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |